Aaron S Kesselheim1. Show Affiliations » 1. Program on Regulation, Therapeutics, and Law (PORTAL), Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
Abstract
Entities: Chemical
Mesh： See more » Alzheimer DiseaseAmyloid beta-PeptidesAntibodies, Monoclonal, Humanized/adverse effectsDrug ApprovalHumansUnited StatesUnited States Food and Drug Administration
Substances： See more » Amyloid beta-PeptidesAntibodies, Monoclonal, Humanizedaducanumab
Year: 2022 PMID： 35174494 DOI： 10.1002/cpt.2546
Source DB: PubMed Journal: Clin Pharmacol Ther ISSN： 0009-9236 Impact factor: 6.875